Literature DB >> 6477508

Two-dimensional polyacrylamide-gel electrophoresis of the proteins and glycoproteins of purified human platelet surface and intracellular membranes.

N Hack, N Crawford.   

Abstract

By using highly purified surface and intracellular membrane fractions prepared from human platelets by free-flow electrophoresis, the polypeptide and glycopeptides of these membranes have been characterized by high-resolution gel electrophoresis under reducing and non-reducing conditions. Silver staining and a variety of glycoprotein-staining procedures have been applied to identify the major components. The principal finding was the clear disparity between the distribution patterns for these two membrane fractions. There are proportionately more low-Mr acidic components present in the intracellular membrane than in the surface-derived membrane. Of the major platelet surface glycoproteins GPIb, IIb, IIIa and IIIb (or IV) well expressed in the surface membrane only, GPIIb and IIIa appear as trace components in the intracellular membrane. The cytoskeleton proteins, actin, myosin, tropomyosin, actin-binding protein and alpha-actinin are prominent features of the surface membrane and essentially absent from the intracellular membrane. Neuraminidase treatment at the whole-cell level, before homogenization, which is an essential requirement for good resolution of the two membrane subfractions, modifies a number of the glycoprotein subunits with respect to their pI characteristics, suggesting much molecular micro-heterogeneity with respect to sialic acid content. A comparison of the staining characteristics of the major glycoproteins with periodic acid/Schiff's reagent and concanavalin A/peroxidase detection and a combined procedure revealed significant differences in associated carbohydrate structures, and the major concanavalin A-binding component was shown to be GPIIIa. These observations are discussed in the context of functional activities of both membrane systems in the physiological behaviour of the platelet.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477508      PMCID: PMC1144165          DOI: 10.1042/bj2220235

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis.

Authors:  J M Gerrard; J G White
Journal:  Prog Hemost Thromb       Date:  1978

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  High resolution two-dimensional gel electrophoresis of the proteins and glycoproteins of human blood platelets and platelet membranes.

Authors:  K J Clemetson; A Capitanio; E F Lüscher
Journal:  Biochim Biophys Acta       Date:  1979-05-03

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

6.  Characterization of human platelet surface and intracellular membranes isolated by free flow electrophoresis.

Authors:  S Menashi; H Weintroub; N Crawford
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

7.  Studies on platelet plasma membranes. IV. Quantitative analysis of platelet membrane glycoproteins by (125I)-diazotized diiodosulfanilic acid labeling and SDS-polyacrylamide gel electrophoresis.

Authors:  J N George
Journal:  J Lab Clin Med       Date:  1978-09

8.  A simple and efficient method for platelet isolation from their plasma.

Authors:  M Lagarde; P A Bryon; M Guichardant; M Dechavanne
Journal:  Thromb Res       Date:  1980 Feb 1-15       Impact factor: 3.944

9.  Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes.

Authors:  M Lagarde; S Menashi; N Crawford
Journal:  FEBS Lett       Date:  1981-02-09       Impact factor: 4.124

10.  Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis.

Authors:  J L McGregor; K J Clemetson; E James; A Capitanio; T Greenland; E F Lüscher; M Dechavanne
Journal:  Eur J Biochem       Date:  1981-05-15
View more
  6 in total

1.  Further characterization of the plasma membrane- and intracellular membrane-associated platelet Ca2+ transport systems.

Authors:  J Enouf; R Bredoux; N Bourdeau; B Sarkadi; S Levy-Toledano
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  A monoclonal antibody (PL/IM 430) to human platelet intracellular membranes which inhibits the uptake of Ca2+ without affecting the Ca2+ +Mg2+-ATPase.

Authors:  N Hack; J M Wilkinson; N Crawford
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

3.  Studies on the bivalent-cation-activated ATPase activities of highly purified human platelet surface and intracellular membranes.

Authors:  N Hack; M Croset; N Crawford
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

4.  Comparative study of different glycating agents on human plasma and vascular cells.

Authors:  Rashmi S Tupe; Nilima Bangar; Arundhati Diwan; Dhanashri Changale; Shivani Choudhary; Shubhangi Chaware
Journal:  Mol Biol Rep       Date:  2019-11-12       Impact factor: 2.316

5.  T-antigen (Gal β3 GaINAc α-) containing glycoproteins of human reace.

Authors:  M Madhan; M Venkataraman; Z Bobby; P H Ananthanarayanan
Journal:  Indian J Clin Biochem       Date:  1999-07

6.  Inositol 1,4,5-trisphosphate-induced release of sequestered Ca2+ from highly purified human platelet intracellular membranes.

Authors:  K S Authi; N Crawford
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.